AVALO THERAPEUTICS INC (AVTX)
US05338F3064 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.4M -19.40% | 18.05M 234.26% | 1.924M -89.34% | 216.495K -88.75% | -100.00% | 280.22M | 674.89M 140.84% | ||||
| EBITDA YoY % growth | -80.47M -77.05% | -37.27M 53.68% | -23.286M 37.52% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -82.13M -73.67% | -37.44M 54.41% | -23.444M 37.38% | -70.139M -199.18% | -53.32M 23.98% | -55.956M -4.94% | -65.28M -16.66% | -72.42M -10.94% | 173.01M 338.90% | 447.4M 158.60% | |
| Operating Margin | -1,520.93% | -207.42% | -1,218.50% | -32,397.41% | N/A | N/A | N/A | N/A | 61.74% | 66.29% | |
| EPS YoY % growth | -9.96 5.68% | -253.04 -2,440.56% | -488.22 -92.94% | -37.22 92.38% | -4.79 87.12% | -3.06 36.17% | 1.28 141.67% | 9.25 625.60% | 12.32 33.19% | 15.00 21.77% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.14 99.02% | -1.15 99.18% | -1.13 91.95% | -1.17 6.16% | -1.15 -1.35% |
| Revenue Q2Q % growth | -100.00% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -12.75M -239.91% | -12.954M -147.78% | -12.954M 11.87% | -13.464M -4.69% | -13.464M -5.60% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.25 95.27% | -1.21 | -0.04 | -2.98% |
| Q2 2024 Q2Q % growth | -14.07 90.06% | -6.83 | -7.24 | -105.88% |
| Q1 2024 Q2Q % growth | -141.00 30.88% | -1.20 | -139.80 | -11,614.86% |
| Q4 2023 Q2Q % growth | -116.22 53.44% | -4.90 | -111.32 | -2,273.67% |
| Q3 2023 Q2Q % growth | -26.40 -7,864.71% | -269.28 | 242.88 | 90.20% |
| Q2 2023 Q2Q % growth | -141.60 -10,160.87% | -195.84 | 54.24 | 27.70% |
| Q1 2023 Q2Q % growth | -204.00 -8,400.00% | -237.46 | 33.46 | 14.09% |
| Q4 2022 Q2Q % growth | -249.60 -12,900.00% | -179.52 | -70.08 | -39.04% |
| Q3 2022 Q2Q % growth | 0.34 116.67% | -1.12 | 1.46 | 130.44% |
| Q2 2022 Q2Q % growth | -1.38 36.11% | -1.81 | 0.43 | 23.56% |
| Q1 2022 Q2Q % growth | -2.40 37.50% | -1.63 | -0.77 | -47.06% |
| Q4 2021 Q2Q % growth | -1.92 11.11% | -1.93 | 0.01 | 0.72% |
| Q3 2021 Q2Q % growth | -2.04 | -2.20 | 0.16 | 7.41% |
| Q2 2021 Q2Q % growth | -2.16 5.26% | -2.08 | -0.08 | -3.81% |
| Q1 2021 Q2Q % growth | -3.84 5.88% | -2.37 | -1.47 | -62.27% |
| Q4 2020 Q2Q % growth | -2.16 -700.00% | -1.84 | -0.32 | -17.65% |
| Q3 2020 Q2Q % growth | -2.04 -142.86% | -1.16 | -0.88 | -75.44% |
| Q2 2020 Q2Q % growth | -2.28 -72.73% | -1.29 | -0.99 | -77.40% |
| Q1 2020 Q2Q % growth | -4.08 -161.54% | -1.25 | -2.83 | -226.80% |
| Q4 2019 Q2Q % growth | 0.36 | 0.86 | -0.50 | -57.98% |
| Q3 2019 Q2Q % growth | -0.84 | -1.63 | 0.79 | 48.53% |
| Q2 2019 Q2Q % growth | -1.32 | -1.77 | 0.45 | 25.63% |
| Q1 2019 Q2Q % growth | -1.56 | -2.00 | 0.44 | 21.97% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 249K 5.51% | 249K | % | |
| Q2 2024 Q2Q % growth | -100.00% | % | ||
| Q1 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | 571K -36.56% | 306K | 265K | 86.60% |
| Q3 2023 Q2Q % growth | 236K -98.42% | 1.02M | -784K | -76.86% |
| Q2 2023 Q2Q % growth | 643K -37.57% | 510K | 133K | 26.08% |
| Q1 2023 Q2Q % growth | 475K -59.40% | 1.02M | -545K | -53.43% |
| Q4 2022 Q2Q % growth | 900K 309.09% | 3.683M | -2.783M | -75.56% |
| Q3 2022 Q2Q % growth | 14.95M 1,007.41% | 1.099M | 13.851M | 1,260.33% |
| Q2 2022 Q2Q % growth | 1.03M -69.35% | 806.82K | 223.18K | 27.66% |
| Q1 2022 Q2Q % growth | 1.17M 148.94% | 380.797K | 789.203K | 207.25% |
| Q4 2021 Q2Q % growth | 220K -85.33% | 1.038M | -818K | -78.81% |
| Q3 2021 Q2Q % growth | 1.35M 21.62% | 1.138M | 212K | 18.63% |
| Q2 2021 Q2Q % growth | 3.36M 150.75% | 3.629M | -269K | -7.41% |
| Q1 2021 Q2Q % growth | 470K -82.91% | 3.855M | -3.385M | -87.81% |
| Q4 2020 Q2Q % growth | 1.5M 158.62% | 1.02M | 480K | 47.06% |
| Q3 2020 Q2Q % growth | 1.11M -49.55% | 1.53M | -420K | -27.45% |
| Q2 2020 Q2Q % growth | 1.34M -3.60% | 2.295M | -955K | -41.61% |
| Q1 2020 Q2Q % growth | 2.75M 6.59% | 1.981M | 769K | 38.82% |
| Q4 2019 Q2Q % growth | 580K | 12.657M | -12.077M | -95.42% |
| Q3 2019 Q2Q % growth | 2.2M | 5.042M | -2.842M | -56.37% |
| Q2 2019 Q2Q % growth | 1.39M | 5.442M | -4.052M | -74.46% |
| Q1 2019 Q2Q % growth | 2.58M | 4.802M | -2.222M | -46.27% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -346% | 0% | -369.02% |
| Revenue | N/A | N/A | -5.46% | N/A |